POSSIBILITIES OF ULTRASONIC MONITORING OF ENDOMETRIUM AND OVARIES IN PATIENTS AFTER CANCELLATION OF LONG-TERM RECEPTION OF COMBINED ORAL CONTRACEPTIVES WHEN PLANNING PREGNANCY

Abstract

The article aims to assess the possibility of ultrasound scanning and dopplerstudy in the assessment of the condition of the ovaries and endometrial in patients after long intake of COC, predicting the restoration of reproductive function after the abolition of hormonal contraception. Material and methods. In 2018-2019, 37 women were examined after the abolition of oral contraceptives, which they took for a long period of time. At the time of the examination, all the patients stopped taking COC at least 2 months ago due to the fact that they were planning a pregnancy. UW the study was conducted on the apparat Voluson E8 Expert (General Electric), improving the quality of diagnostics used Automatic assessment of follicle condition based on ultrasonic echography (Sono AVCTM follicle) and tomographic ultrasound (TUI). Results. According to the study significant changes recorded 17 patients whose menstrual cycle did not recover within the first 6 months after the cancellation of COC. In a group of 20 patients with a regular menstrual cycle, the results of the study were within normal limits, pregnancy within 6 months occurred on their own in 8 of them. Conclusion. The possibilities of 3 dimensional reconstruction and programs for evaluating the follicular apparatus significantly improve the quality of ultrasound diagnostics, give more information about the presence of small follicles, blood flow in the ovarian tissue, the structure of the cortical apparatus substances and stroma, whichis the ability of a clinician to obtain a complete understanding of the condition of the ovaries and endometrial and predicting a good health of patients. The article may be of interest to obstetricians-gynecologists, ultrasound specialists, endocrinologists, reproductive specialists.

Keywords

oral contraceptives / fertility / ultrasound

References

[1] Черипко М.В., Иванов И.И., Попова-Петросян Е.В., Прочан Е.Н. Клинические аспекты приема оральных контрацептивов. Таврический медико-биологический вестник. 2017; 20 (3-1): 106-9

[2] Iversen L., Sivasubramaniam S., Lee A.J., Fielding S., Hannaford P.C. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am. J. Obstet. Gynecol. 2017; 216 (6): 580.e1-e9. doi: 10.1016/j.ajog.2017.02.002

[3] Прожерина Ю., Широкова И. Гормональная контрацепция как путь к сохранению репродуктивного здоровья. Ремедиум. 2016; (5): 39-42.

[4] Кузнецова И.В., Евсюкова Л.В., Коновалов В.А. Комбинированная оральная контрацепция. Есть ли ресурс для расширения использования? Медицинский совет. 2018; (12): 146-51. https:doi.org/10.21518/2079-701X-2018-12-146-151

[5] Боярский К.Ю., Гайдуков С.Н., Чинчаладзе А.С. Факторы, определяющие овариальный резерв женщины. Журнал акушерства и женских болезней. 2009; (2): 65-71.

[6] Letourneau J.M., Cakmak H., Quinn M. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield. J. Assist. Reprod. Genet. 2017; 34(9): 1137-44.

[7] Coelho Neto M.A., Ludwin A., Borrell A., Benacerraf B., Dewailly D., da Silva Costa F. et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet. Gynecol. 2018; 51 (1): 10-20. doi: 10.1002/uog.18945

[8] Voluson™ E8 BT15. Основное руководство пользователя. H48691TU. Revision 3 (M3) GE Healthcare Austria, GmbH & Co OG, 2015.

[9] Озерская И.А. Эхография в гинекологии. М.: Видар; 2013.

RIGHTS & PERMISSIONS

Eco-Vector